Update: Anemia and Chronic Kidney Disease
This new KDOQI guideline will examine the impact anemia has on outcomes of patients with CKD. The original KDOQI guidelines addressed anemia in kidney failure. This new work will update existing guidelines and provide new recommendations for the identification and treatment of anemia in all stages of CKD. The work group continues to meet and develop the guidelines in anticipation of fourth quarter 2005 publication date.
Work Group and Evidence Review Team Membership
Chairs:
David B. VanWyck, MD
Kidney Health Institute, LLC
Tucson, AZ
Kai-Uwe Eckardt, MD
University of Erlangen-Nuremberg
Erlangen, GERMANY
Work Group:
John Adamson, MD
George R. Bailie, PharmD, MD
Jeffrey S. Berns, MD
Steven Fishbane, MD
Robert Foley, MD
Sana Ghaddar, RD, PhD
John Gill, MD
Kathy Jabs, MD
Hans Messner, MD
Allen R. Nissenson, MD
Gregorio T. Obrador, MD
John C. Stivelman, MD
Colin White, MD
Patricia B. McCarley, RN, MSN, NP
European Best Practices Group Liaisons:
Francesco Locatelli, MD
Iain MacDougall, MD
Evidence Review Team:
Joseph Lau, MD
Ethan Balk, MD
George Fares
Katrin Uhlig, MD
New England Medical Center
Boston, MA
